一个对重症病人,有4个arms 一个对轻中症病人。
https://clinicaltrials.gov/ct2/show/study/NCT04292899?term=remdesivir&recrs=ad&cond=COVID&draw=2&rank=2
https://clinicaltrials.gov/ct2/show/NCT04292730?term=remdesivir&recrs=ad&cond=COVID&draw=2&rank=3
下面那位xycheese网友陈述有误,说她妈妈被分到安慰剂组。其实根本没有安慰剂组,只有瑞德西韦对比standard of care
4月份一个医生对Gilead的建议: Dear Gilead: Please Add a Placebo Arm to Remdesivir Trial
五月出结果,很快大家就知道了
都不一样呢?
https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19
xycheese网友不是陈述有误, 是胡编烂造。
and FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment based on the results of this trial.
From the ACTT trial which will run till April 2023.
Its preliminary data are good and promising.
一个对重症病人,有4个arms
一个对轻中症病人。
https://clinicaltrials.gov/ct2/show/study/NCT04292899?term=remdesivir&recrs=ad&cond=COVID&draw=2&rank=2
https://clinicaltrials.gov/ct2/show/NCT04292730?term=remdesivir&recrs=ad&cond=COVID&draw=2&rank=3
下面那位xycheese网友陈述有误,说她妈妈被分到安慰剂组。其实根本没有安慰剂组,只有瑞德西韦对比standard of care
4月份一个医生对Gilead的建议:
Dear Gilead: Please Add a Placebo Arm to Remdesivir Trial
五月出结果,很快大家就知道了
逛坛子也只找和家人有关的。太不关心自己了
都不一样呢?
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19
https://www.gilead.com/news-and-press/press-room/press-releases/2020/4/gilead-announces-results-from-phase-3-trial-of-investigational-antiviral-remdesivir-in-patients-with-severe-covid-19
xycheese网友不是陈述有误, 是胡编烂造。
and FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment based on the results of this trial.
From the ACTT trial which will run till April 2023.
Its preliminary data are good and promising.